GENFIT S.A. - American Depositary Shares (NQ:GNFT)

4.850 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GENFIT S.A. - American Depositary Shares

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 28, 2021

Gainers China SXT Pharmaceuticals (NASDAQ:SXT...

Via Benzinga

51 Biggest Movers From Yesterday ↗

December 28, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

December 27, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...

Via Benzinga

Why Genfit Shares Are Rising ↗

December 17, 2021

Genfit SA (NASDAQ: GNFT) shares are trading higher after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. David Loew, Chief Executive...

Via Benzinga

15 Stocks Moving in Monday's Pre-Market Session ↗

December 27, 2021

15 stocks that should be interesting to investors.

Via Talk Markets

15 Stocks Moving in Monday's Pre-Market Session ↗

December 27, 2021

Gainers IceCure Medical Ltd (NASDAQ: ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering...

Via Benzinga

Christmas is Coming ↗

December 23, 2021

November saw a very modest increase in consumer spending, 0.6%. That means we are probably making up for it this month.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 22, 2021

Gainers BioCardia (NASDAQ:BCDA) shares ro...

Via Benzinga

A Bit Of Good News ↗

December 22, 2021

US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.

Via Talk Markets

Plague Year Reversal ↗

December 21, 2021

Just in time for Christmas, the market decided to go up today pretty much across the board.

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 21, 2021

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 21, 2021

Good morning, trader! We're kicking off the day with a dive into some of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

26 Stocks Moving in Tuesday's Pre-Market Session ↗

December 21, 2021

Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains...

Via Benzinga

Dreaming Of A Red Christmas ↗

December 20, 2021

The stock market is reacting with lots of selling to the weekend's news.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021 ↗

December 20, 2021

Upgrades According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp (NASDAQ:...

Via Benzinga

Mid-Afternoon Market Update: Crude Oil Drops Over 2%; Bottomline Technologies Shares Spike Higher ↗

December 17, 2021

Toward the end of trading Friday, the Dow traded down 0.87% to 35,585.26 while the NASDAQ rose 0.43% to 15,245.07. The S&P also fell, dropping 0.32% to 4,653.92. The U.S. has...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GN...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

Major Benchmarks Mixed With Weekly Losses Likely ↗

December 17, 2021

The Dow Jones Industrial Average is extending this morning's losses,the S&P 500 Index has joined the Dow in the red, while the Nasdaq Composite has managed to climb back above its breakeven

Via Talk Markets

Mid-Day Market Update: Dow Tumbles 500 Points; Abeona Therapeutics Shares Plummet ↗

December 17, 2021

Midway through trading Friday, the Dow traded down 1.39% to 35,398 while the NASDAQ fell 0.30% to 15,134.89. The S&P also fell, dropping 0.92% to 4,625.58. The U.S. has the...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...

Via Benzinga

GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters ↗

December 17, 2021

Genfit (GNFT) stock is rocketing higher on Friday after the company signed an exclusive licensing agreement with Ipsen (IPSEY).

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings ↗

December 17, 2021

Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&P also fell, dropping 1% to 4,622.16. The U.S. has...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GNFT) stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4...

Via Benzinga

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗

December 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 17, 2021

Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (...

Via Benzinga

Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful ↗

December 17, 2021

Ipsen SA (OTC: IPSEY) has entered into a long-term strategic partnership to develop, manufacture, and commercialize and Genfit SA's (NASDAQ: GNFT)...

Via Benzinga

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership

December 17, 2021

From Ipsen and GENFIT

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.